Literature DB >> 27572273

MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways.

Pengcheng Sun1, Lu Wang1, Yunhan Lu1, Yuwei Liu1, Lechen Li1, Luyao Yin1, Cheng Zhang2, Weiming Zhao2, Baozhong Shen3, Wanhai Xu1.   

Abstract

Increasing evidence indicates that dysregulation of miR-195 may contribute to the occurrence and development of multiple types of human malignancies. However, the function and the mechanism of miR-195 in clear cell renal cell carcinoma (ccRCC) are still not fully understood. In the present study, we used qRT-PCR to detect the expression of miR-195 in ccRCC tissues and normal kidney tissues. MTT assay was performed to detect the cell viability of miR-195. Migration and invasion were evaluated by Transwell migration and Matrigel invasion assays, respectively. Additionally, apoptosis levels were evaluated using TUNEL assays, and signaling pathway changes were determined by western blot analysis. We observed that miR-195 was downregulated in clear cell renal cell carcinoma samples compared with normal renal samples. We identified that overexpression of miR-195 inhibited ACHN cell viability, migration, invasion, and it also induced cell apoptosis by targeting VEGFR2 via PI3K/Akt and Raf/MEK/ERK signaling pathways. These findings indicate that miR-195 has a tumor suppressive role in ACHN cells and miR-195 may be a promising candidate target for prevention and treatment of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572273     DOI: 10.3892/ijo.2016.3608

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3/microRNA-195-5p/SGK1.

Authors:  Shu-Cheng Liu; Li-Bo Chen; Ping-Feng Chen; Meng-Long Huang; Tian-Pei Liu; Jun Peng; Xin-Sheng Lu
Journal:  Clin Epigenetics       Date:  2022-10-20       Impact factor: 7.259

2.  Prostate cancer health disparities: An immuno-biological perspective.

Authors:  Sanjay Kumar; Rajesh Singh; Shalie Malik; Upender Manne; Manoj Mishra
Journal:  Cancer Lett       Date:  2017-11-15       Impact factor: 8.679

3.  Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.

Authors:  Xiao-Zhong Liao; Lan-Ting Tao; Jia-Hui Liu; Yue-Yu Gu; Jun Xie; Yuling Chen; Mei-Gui Lin; Tao-Li Liu; Dong-Mei Wang; Hai-Yan Guo; Sui-Lin Mo
Journal:  Cancer Cell Int       Date:  2017-12-28       Impact factor: 5.722

4.  MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value.

Authors:  Sandra Gallach; Eloisa Jantus-Lewintre; Silvia Calabuig-Fariñas; David Montaner; Sergio Alonso; Rafael Sirera; Ana Blasco; Marta Usó; Ricardo Guijarro; Miguel Martorell; Carlos Camps
Journal:  Oncotarget       Date:  2017-06-22

Review 5.  Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma.

Authors:  Antonella Argentiero; Antonio Giovanni Solimando; Markus Krebs; Patrizia Leone; Nicola Susca; Oronzo Brunetti; Vito Racanelli; Angelo Vacca; Nicola Silvestris
Journal:  J Clin Med       Date:  2020-05-24       Impact factor: 4.241

6.  Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression.

Authors:  Keng Lin; Hao Chen; Chunyan Su; Huanjin Zhu; Changchun Lai; Yaling Shi
Journal:  Cancer Manag Res       Date:  2020-05-04       Impact factor: 3.989

Review 7.  MicroRNA-195: a review of its role in cancers.

Authors:  Wanpeng Yu; Xiao Liang; Xiangdong Li; Yuan Zhang; Zhenqing Sun; Ying Liu; Jianxun Wang
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

8.  FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.

Authors:  Qi Lv; Gangmin Wang; Yinan Zhang; Xiao Han; Haoming Li; Wei Le; Minguang Zhang; Chunhui Ma; Peijun Wang; Qiang Ding
Journal:  Int J Oncol       Date:  2019-02-22       Impact factor: 5.650

9.  MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis.

Authors:  Ni Wang; Yang Cao; Xianxiu Ge; Junjie Nie; Yang Yu; Quanpeng Li; Fei Wang; Lin Miao
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

Review 10.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.